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Epidermal Growth Factor Receptor (EGFR) plays a key role in regulating cell survival, 
proliferation and migration, and its overexpression and activation has been correlated 
with cancer progression. Cancer therapies targeting EGFR have been applied in the 
clinic with some success. We show, by confocal microscopy analysis, that illumination 
of adenocarcinomic human alveolar basal epithelial cells (Human A549 – EGFR 
biosensor cell line) with 280 nm at irradiance levels up to 20 times weaker than the 
UVB solar output for short periods of time (15-45 min) prevents EGF-mediated 
activation of EGFR located on the cell membrane, preventing or reducing cellular 
disaggregation, formation of filopodia and cell migration. This effect of UV light 
illumination was confirmed further in a functional scratch assay, and shown to be more 
effective than that of a specific EGFR-signaling inhibitor. This new photonic approach 
may be applicable to the treatment of various types of cancer, alone or in combination 
with other therapies. 
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1. Introduction  
Many current cancer therapies aim at inhibiting the epidermal growth factor 
receptor, EGFR. EGFR is a membrane receptor that plays a key role in regulating cell 
survival and proliferation [1–5], being a member of the ErbB family of receptor tyrosine 
kinases (RTKs) [6]. EGFR binds to ligands, such as epidermal growth factor (EGF) 
leading to receptor dimerization and activation of the tyrosine kinase domain [7–9]. 
This leads to downstream activation of signal transduction cascades, mainly the MAPK, 
Akt and JNK pathways [10,11]. These pathways modulate cell migration, adhesion and 
proliferation.  
High expression of EGFR is generally associated with cancer progression, 
invasion, metastasis, late-stage disease, chemotherapy resistance, hormonal therapy 
resistance and poor general therapeutic outcome [8,12-15]. Typical chemotherapeutical 
agents are tyrosine kinase inhibitors that compete with ATP at the intracellular tyrosine 
kinase domain [6,9,12] and monoclonal antibodies (mAbs) [6,9,13] that prevent ligand-
binding or receptor dimerization. Blocking EGF binding to EGFR can abolish cancer 
proliferation, invasion, metastasis, angiogenesis and inhibition of apoptosis. It is known 
that the structure of EGFR can be altered and rendered inactive by 280 nm light, 
impairing the correct binding of ligands [16,17]. Furthermore, 280 nm irradiation leads 
to the arrest of EGFR dependent key signaling pathways [14].  
In the present study we show that illumination of lung carcinoma cells with low 
dose UVB (0.09 W/m2 – 0.27 W/m2 at 280 nm) inhibits EGF-mediated activation of 
EGFR. Importantly, we screened for the effect of irradiation on the formation of 
filopodia and on cellular migration promoted by EGFR activation. These irradiance 
values, applied for short periods of time (15-45 min), are up to 20 times weaker than the 
UVB levels in the solar output. The effect of UV irradiation on cellular migration was 
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also compared to the effect of Tyrphostin AG1478, a specific EGFR signaling inhibitor 
[18]. Our goal is to develop a new photonic therapy that reduces uncontrolled migration 
of cancer cells, as well as their invasiveness. Taking this technique from the bench to 
the clinical practice would be straightforward, when compared to other photonic based 
techniques, as little secondary or deleterious effects are foreseen when using such low 
power light.  
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2. Materials and Methods 
2.1.Cell line  
The main cell line used in this study was the A549-GFP-tagged SH2 biosensor 
cell line (Sigma-Aldrich, CLL1141) [19]. The SH2 domain protein, fused to green 
fluorescent protein (GFP), has high affinity for receptor tyrosine kinases, acting as a 
biosensor of endogenous EGFR activity. Upon ligand binding, activation of receptor 
tyrosine kinases and consequent phosphorylation of tyrosine residues leads to 
recruitment of the chimeric SH2 domain–based biosensor, followed by receptor 
endocytosis and recycling. EGFR function in live cells may then be evaluated by the 
formation of green granules [20-22].  
 The cells were kept at 37º C in a 5% CO2 atmosphere. Cells were cultured in 
Dulbecco's Modified Eagle Medium (DMEM) with 2 mM glutamine, 1 µg/mL 
puromycin (complete medium) and 10% of fetal bovine serum (FBS).  The parental cell 
line A549 (human lung carcinoma) was used in the proliferation assay, as a control. All 
reagents were purchased from Sigma-Aldrich except otherwise stated. 
 
2.2.Proliferation assay 
Cell proliferation was determined by two methods, Sulphorhodamine B (SRB) 
and Resazurin. For the SRB, A549-GFP cells were seeded in 96-well plates (105 
cells/mL) and incubated overnight at 37 oC in 5% CO2 atmosphere. The culture medium 
was replaced by DMEM containing 2% of FBS and EGF (0.1 nM to 2nM). After 24h, 
the cells were washed with PBS and fixed with 1% acetic acid in 100% methanol 
solution. 0.5 % of SRB (in 1% acetic acid) was added to each well and incubated at 
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37oC for 1 h, followed by 3 washes with 1% acetic acid solution. SRB was dissolved 
with 10mM Tris solution and absorbance read at 540nm.  
For the Resazurin assay, cells (A549 and A549-GFP) were seeded in 24-well 
plates (2.2x104 cells/mL) and incubated overnight at 37oC in 5% CO2 atmosphere. The 
culture medium was replaced by DMEM containing 2% of FBS and EGF (0nM to 
32nM). 8h after the first EGF stimulus, the cells were incubated for 2 h with resazurin 
and the respective absorbance measured at 600 nm. Fresh culture medium with EGF 
was added to cells and incubated for an additional 8 h. This protocol was repeated to 
evaluate cell proliferation.  
We proceeded to determine if 280 nm illumination changes the proliferation of 
A549 GFP cells stimulated with 2nM EGF. The cells were seeded in 24-well plates 
(2.2x104 cells/mL) and incubated overnight at 37oC in 5% CO2 atmosphere. The cells 
were irradiated at a wavelength of 280 nm with irradiance of 0.27 W/m2 for 30 min. 
After this period, the culture medium was replaced by DMEM containing 2% FBS and 
2 nM EGF. 8h after the first EGF stimulus, the Resazurin assay was performed as 
described. At this point, fresh culture medium with 2 nM EGF was added to the cell 
culture and after an incubation of 8h the resazurin assay was repeated. The statistical 
analysis was performed using the Statistical Package for the Social Sciences (SPSS). 
 
2.3.Migration assay 
A549-GFP cells were seeded into 12 well plates (2.2x104 cells/mL) and 
incubated overnight at 37oC in 5% CO2 atmosphere. A scratch was performed disrupting 
the confluent cell monolayer. In order to assess the influence of the UV light (280 nm) 
on cell migration, the cells were irradiated at 280 nm (LED) with irradiance of 0.27 
W/m2 for 30 min. The culture medium was replaced by DMEM containing 2% of FBS, 
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EGF (0 nM or 2 nM). Where appropriate, 1µM Thyrphostin AG1478 (Thyr), a specific 
EGFR signaling tyrosine kinase inhibitor shown to be effective in A549 cells [19], was 
added. Cell migration was followed by phase contrast microscopy for a period of 20 h, 
sufficient for scratch closure. Three micrographs of each experimental condition were 
taken at every timepoint with the 10x objective. The area devoid of cells at 0h and 20h 
was calculated in pixels using the MRI Wound Healing Tool macro for open-software 
platform ImageJ and the percentage of reduction in scratch area between the first and 
last timepoints was calculated. The values in wound area variation were calculated and 
indicated in Figure 4 (mean of 3 different images of the same experiment ± standard 
deviation). 
 
2.4.UVB (280 nm) illumination setup 
Illumination prior to Confocal Laser Scanning Microscopy 
280 nm illumination was provided by the Xe arc lamp (LX 300UV) of an ISS 
Chronos BH steady state fluorometer with a computer controlled monochromator. The 
light was focused onto an optical fiber with a core diameter of 150 μm. Light intensity 
was adjusted by regulating the lamp current between 10 and 18 A and by adjusting the 
monochromator slit width from 8 nm to 16 nm. Light was shaped to a 1 cm diameter 
circular beam and passed centrally through the excitation volume. The cells were 
illuminated for 15 min and 30 min with 280 nm light at 0.27 W/m2 (0.021 mW, 10 A, 
slit width 16 nm) and 0.09 W/m2 (0.007 mW, 10 A, slit widths 8 nm). An additional 
experiment was carried out illuminating the cells with 280nm light at an irradiance of 
1.18 W/m2 (0.093mW, 18A, slit width 16nm) for 15min and 45 min. The temperature of 
the sample was kept at room temperature (~22ºC) during illumination. The irradiance 
levels used (0.09 W/m2, 0.27 W/m2 and 1.18 W/m2) were chosen based on data 
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previously published by our group and based on the irradiance levels in the UVB 
domain emitted by the sun. Correia et al. [16] demonstrated that irradiation of EGFR 
with UVB light (280 nm) at an irradiance level of 0.08 W/m2 induced structural changes 
in the receptor. Furthermore, Olsen et al. [14] demonstrated that the irradiation of two 
cell lines overexpressing EGFR, A431 (human epidermoid carcinoma cells) and Cal39 
(derived from human vulva squamous cell carcinoma cells), with an irradiance of 0.35 
W/m2, blocks the EGFR signaling pathway. The chosen irradiance levels are up to 22 
times weaker than the UVB solar output. The sunlight irradiance of the UVB region is 
reported to be 1.75 W/m2 at 39 º [15] 
 
Illumination prior to the Migration assay 
The cells were illuminated with a high power Fiber-Coupled 280nm LED 
Light Source controlled by a two-channel LED driver with manual and analog-input 
controls. The high power Fiber-Coupled 280nm LED Light Source (product number 
FCS-0280-000), Multimode Fiber Patchcord, 0.22 NA, 600μm with Core SMA 
Connectors (product number FPC-0600-22-02SMA) and the two-channel LED 
driver with manual and analog-input controls, maximum current 100mA (product 
number SLA-0100-2) were purchased from Azpect (AZPECT PHOTONICS AB, 
Sweden). 
 
2.5.Confocal Laser Scanning Microscopy (CLSM) 
The morphology and the mobility of non-illuminated versus 280 nm illuminated 
cells was monitored using CLSM. All the experiments were carried out at 37 ºC using a 
heat chamber coupled onto the Zeiss-LSM780. The cell medium containing 2% FBS 
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was supplemented with 2 nM EGF. The addition of EGF was considered the time zero 
for the time-lapse experiments.  
To determine if the laser line at 488 nm used to image the green fluorescence of 
A549-GFP cells in the CLSM influenced the observed results, the cells were irradiated 
for 30 min at 488 nm with an irradiance of 0.27 W/m2. Cells were then imaged every 2 
min up to 60 min and imaged only twice, first at time zero and at 60 min after being 
kept in the dark. Non-irradiated cells were kept under the same conditions and imaged 
as a control.  
 
2.6.Statistical analysis 
Data from SRB and Resazurin proliferation assays were analyzed using ANOVA test 
with Bonferroni as a post-hoc test, with significance level defined at p<0.05. 
 
3. Results 
3.1.A549-GFP cells are a good model to evaluate effect of light on EGF-
mediated activation 
 
To validate the experimental model and settings used throughout the study, 
several control experiments were performed. The cell line used, A549-GFP-tagged SH2 
biosensor cell line, expresses a fluorescent chimeric fusion protein: an EGFR protein 
tagged with GFP. EGF-mediated activation leads to redistribution of EGFR (and, thus, 
of GFP) from the cell membrane to endosomes. 
These cells were irradiated with 280 nm light ranging between 0.09 and 1.18 
W/m2. The highest irradiation level (1.18 W/m2) did not induce EGFR activation, 
fluorescence bleaching or morphological changes of the cancer cells. The putative 
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bleaching effect (not observed) would be even lower in the experiments using a lower 
irradiance, as done in the present study. Similarly, the exposure to the wavelength of 
488 nm in the Confocal Scanning Laser Microscope (CLSM) did not induce any 
morphological changes to the confluent cell monolayer or activated the EGFR, 
irrespectively to exposure time (every 2 min for 60 min or twice in 60 min). The same 
was observed with the control cells kept in the dark during these 60 min. 
 The proliferation rate of A549-GFP cells tends to be highest when the cells are 
stimulated with 2 nM EGF (Fig. 1, SRB method). However, although consistent, the 
differences observed are not statistically significant (p>0.05). Different EGF 
concentrations were screened to identify 2nM as the optimal concentration to stimulate 
proliferation in A549-GFP-tagged SH2 biosensor cells. Figure S1-A shows that, 
although there is consistently a natural increase in cell proliferation (measured by SRB 
assay) from 8h to 24h in presence of 2nM EGF, such increase is not paramount. Figure 
S1-B illustrates an experiment where we followed the proliferation of these cells 
stimulated with 2nM EGF over 4 days; it shows that after a peak at day 1, the cells tend 
to invert growth even with continuous EGF stimulation; this was observed by us in 
other experiments not shown here. Figure S1-C shows yet another independent 
experiment (MTT assay) where it is clarified that it is important to remove or reduce 
bovine serum in the culture medium to evaluate proliferation of A549-EGFR biosensor 
cells at 24h in presence of 2nM EGF.  
 An additional proliferation experiment was performed with resazurin to compare 
A549-GFP cells and the parental cell line (A549) (Fig. 2). Both cell lines were 
stimulated with EGF at two different time points. Data shows a similar behavior in 
parental A549 cells and in the reporter cell line A549-GFP. No statistically significant 
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differences were detected in the proliferation of A549 when compared the A549-GFP 
cells stimulated with different EGF concentrations (p>0.05). 
 
3.2.UV illumination does not affect cell proliferation but influences motility of 
A549-GFP cells 
To determine if 280nm illumination directly affects EGF-induced proliferation 
of A549-GFP cells, these were irradiated prior to stimulation with 2 nM EGF every 8 h 
to maintain EGF bioavailable (Fig. 3). Figure S1-C shows that either maintaining EGF 
for 24h or renewing it every 8h to ensure its bioavailability in the medium leads to 
similar results prior to light treatments. As EGFR only remains active for less than 2 
hours after stimulation of the cells [23] and DNA synthesis requires more than 8 hours 
of exposure to EGF, therefore, as described by others [23], renewal of EGF in the 
medium every 8h should stimulate cell proliferation. Therefore, cell proliferation was 
monitored up to 16h after the light pretreatment (before and after the renewal of EGF in 
the medium) as it would more reliably indicate the effects during the cell cycle of A549-
EGFR biossensor cells and drastic differences further on would not be expectable. The 
illumination of the cancer cells challenged with 2 nM EGF does not change their 
proliferation profile 8 h after either the first or the second stimulus of EGF. We 
conclude that there are no statistically significant differences (p>0.05) concerning the 
proliferation of A549-GFP cells in the presence or absence of illumination. 
 In order to evaluate, in a functional assay, if cell mobility is altered when EGF-
stimulated cells are irradiated, the scratch test was performed (Fig. 4). The sequential 
images document that, in the presence of 2 nM EGF (+EGF; 74.2 ± 12.4% reduction of 
scratch area between 0h and 20h), non-illuminated A549- GFP cells more rapidly fill 
the scratch compared to non-exposed cells (Control; 69.9 ± 10.3% reduction of scratch 
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area). Thyrphostin AG1478 (Thyr), at the concentration previously shown to inhibit 
EGFR signaling activation in A549 cells, effectively impairs cell migration, with 
(+EGF+Thyr; 59.8 ± 6.6% reduction of scratch area) or without EGF (+Thyr; 42.5 ± 8.0 
% reduction of scratch area) present. Illumination prior to addition of EGF 
(+light+EGF; reduction of scratch area in 2.7 ± 8.5% between 0h and 20h) has a striking 
inhibitory effect and clearly limits cell movement to fill the scratch. Light treatment 
alone (reduction of 0.9 ± 2.0 % of wound area) seems to affect unstimulated cells. 
CLSM data shows that, prior to EGF addition, the cells are in a cohesive monolayer 
(Fig. 5A, panel a-1). After 24 min of exposure to EGF, the activation of EGFR on the 
cell membrane is confirmed by bright green fluorescence observed at the cell membrane 
(Fig. 5A, panel a-2). At this stage, EGFR is predominantly located at cell-cell junctions. 
After 42 min, the formation of filopodia is clear as well as the internalization of the 
activated (phosphorylated) EGFR due to the presence of multiple green granules in the 
cytoplasm (Fig. 5A, panel a-3). Disintegration of the cell monolayer, with significant 
morphological changes and well-formed filopodia is observed 96 min after EGF 
addition (Fig. 5A, panel a-4 and F and Movie S1_Fig5A). In Figure 5B, panel b-1, no 
activation or internalization of EGFR was observed (time zero). However, 102 min after 
EGF addition, the internalization of the complex EGF/EGFR is clear (Fig. 5B, panel b-
2). The presence of EGF results into two distinct phenomena: activation of EGFR at the 
membrane level and loss of the cohesiveness of the cell monolayer with consequent 
filopodia formation.  
 
3.2.1. 0.09 W/m2 illumination series 
 A monolayer of A549-GFP cells was illuminated at 280 nm with an irradiance 
of 0.09 W/m2 for 30 min and 15 min (Figs. 6A, panels a-5 to –a-8 and Fig. 7, 
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respectively, and see Movie S2_Fig6A_A5-A8). Subsequently, the cell monolayer was 
stimulated with 2nM EGF. As a control, A549-GFP cells were stimulated with 2 nM 
EGF in the absence of light (Fig. 6A, panels a-1 to a-4-A4 and see Movie 
S3_Fig6A_A1-A4). EGF addition to non-illuminated cells led to EGFR activation 
visible at the cell membrane of these biosensor cells (Fig. 6A panel a-2). Morphological 
changes and filopodia formation were observed (Fig. 6B panel b-2). Filopodia 
formation 60 minutes after irradiation and subsequent incubation with EGF (Fig. 6A, 
panels a-8) was quantified and compared to the non-illuminated control (Fig. 6A, panels 
a-4) (Figure S2). Illumination of the cells prior to EGF addition (Fig. 6A, panels a-5 to 
a-8) prevented or reduced EGFR activation and no significant morphology changes 
were noted. Formation of filopodia was not observed (Fig. 6A, panels a-5 to a-8 and 
Fig. 6C).  
 When the cell monolayer was illuminated at the same irradiance level 
(0.09W/m2) but for a shorter period of time (15min, see Fig. 7 and Movie S4_Fig7), the 
decrease of EGFR activation is less pronounced when compared to the results obtained 
with 30 min of irradiation (Fig. 6A).  
 
3.2.2. 0.27 W/m2 illumination series 
 Cancer epithelial cells were illuminated with 280 nm light at an irradiance of 
0.27 W/m2 for 15 min (Fig. 8 and Movie S5_Fig8_A-C and Movie S6_Fig8_D-F). For 
the non-illuminated cells, the addition of 2 nM EGF led to brighter cell junctions, 
indicating activation of EGFR (Fig. 8 panels a-1 to a-3), while no significant changes 
are observed if the cells have been illuminated for 15 min before EGF addition (Fig. 8 
panels a-4 to a-6). This fact confirms that illumination prior to stimulation with EGF 
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prevents EGFR activation. Similar results were observed when these cells were 
illuminated for 30 min. 
 
3.2.3. 1.18 W/m2 illumination series 
The cancer cells were then exposed to a higher irradiation level, 1.18W/m2, for 
15 min and 45 min. The new irradiation level is still lower than the maximum solar out 
of 1.75 W/m2 at 39ºN in summer (below 313nm) [15]. 
 As it can be seen in Fig. 9, the irradiation of the cells prior to their stimulation 
with 2nM EGF (Fig. 9 a-2 and a-3) results in significant changes in the fluorescence 
pattern observed in comparison to non-irradiated EGF-stimulated cells (Fig. 9 a-1), 
during imaging for a period of 102 min. 
 In the absence of light (Fig. 9 a-1), EGF leads to significant internalization of 
the dimerized activated receptor, visible as fluorescent granules, altered cell 
morphology and reduced cell-cell contact, as expected. However, as observed in Fig. 9 
a-2, when the cells were pre-exposed to 280 nm light for 15 min, EGF fails to induce 
such striking formation of green fluorescent granules, and a more diffuse pattern, typical 
of non-activated cells, is visible. The irradiation not only decreases EGFR activation, 
but also reduces cell-cell contact disaggregation (Fig. 9 a-2). This observation was even 
more evident when the cells were exposed to 280 nm light for 45 min (Fig. 9 a-3). 
 The images shown represent more than 3 datasets for each experimental 
condition used. Due to the large number of images obtained, not all images were 
presented.  
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4. Discussion 
It is estimated that 33-50% of human carcinomas present an aberrant regulation 
of EGFR expression [8,24–26]. One strategy to reduce the invasiveness of cancer cells 
is to block or halt the activation of EGFR using, for example, antibodies or tyrosine 
kinase inhibitors [6,9,12,13]. It is known that the structure of EGFR can be altered and 
rendered inactive by 280 nm light [16]. The present study confirmed the ability of 280 
nm light to prevent EGF-EGFR activation and disclosed for the first time its inhibitory 
effect on migration of human lung carcinoma cells at irradiance values up to 20 times 
weaker than the UVB solar output and for short periods of time (15-45 min). The new 
findings may be used to design treatment approaches aimed at blocking metastasis 
formation using low level 280 nm light. 
UV exposure is generally believed to cause skin cancer. This belief is only true 
for particular UV wavelengths and not for the whole UV range [27]. In fact, some UV 
wavelengths have therapeutic benefits: UVB (280–315 nm) light has been successfully 
used in the treatment of several skin diseases like psoriasis [28]. The most important 
contributor for vitamin D production is UVB light [28,29]. Sunlight exposure has also 
been associated with improved cancer survival rates [30], as well as preventing colon, 
prostate and breast cancer [31,32]. The International Electrotechnical Commission 
(2009) recommends that the maximum annual exposure should not exceed an 
erythemal-weighted dose of 0.3W/m2 [33]. In this study the doses used were 0.09 and 
0.27 W/m2 for 30min, which correspond to 30% and 90%, respectively, of the 
recommended value to avoid erythema.  
The presence of different concentrations of EGF is known not to have a drastic 
effect on the cell’s proliferation rate [23]. This is corroborated by our results, which 
consistently show a similar behavior in parental A549 cells and in the reporter cell line 
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A549-GFP, and further validate the use of the latter (Figs 1 and 2). In Fig. 3, it is 
possible to observe that the irradiation of cancer cells with 280 nm light, with an 
irradiance of 0.27 W/m2 for a period of 30 min, does not alter the proliferation rate of 
the cells even when stimulated with EGF. However, the same illumination conditions 
reduce cellular migration upon EGF stimulation, even more than with a specific 
pharmacological EGFR signaling inhibitor (Thyrphostin AG1478), as clearly shown in 
Fig. 4. Being an EGFR specific inhibitor, Thyrphostin may interfere with EGFR 
dependent pathways which involve cell proliferation although this specific effect has 
not been described yet.  
In non-illuminated cells, EGF induces visible EGFR activation followed by 
receptor internalization which is in agreement with literature [34,21-22]. The work by 
Silva et al. confirmed that such enhancement of green fluorescence was due to the 
formation of the EGFR-EGF complex, as the presence of an antibody against EGFR has 
prevented EGF binding to EGFR and no enhancement of green fluorescence at the cell 
membrane level and complex internalization were observed [35].  
Disintegration of the cancer cell monolayer is associated with filopodia 
formation (Fig. 5A, panel a-4) and this observation is positively correlated with the 
epithelial-mesenchymal transition (EMT) process [32,36,37]. Activation and 
internalization of EGFR is known to lead to the internalization of E-cadherin, a key 
adhesion protein [38], resulting in the loss of cell junctions adherence and, 
consequently, tissue disaggregation [39]. The present data is positively correlated with 
that proposed mechanism. The invasive phenotype of the cancer cells observed upon 
activation by EGF is supported by the formation of filopodia, visible in Fig. 5A (panel 
a-4) and Fig. 6B (panel b-2). 
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The investigation of the effect of 280 nm light on preventing the activation and 
migration of lung carcinoma cells overexpressing EGFR has been carried out using 
different irradiance values: 0.09, 0.27 and 1.18 W/m2. The two lower levels fall below 
the total irradiance of sunlight in the UVB region (280-315 nm) reported to be ~0.78 
W/m2 [40], and 1.75 W/m2 at 39 ºN in summer and 0.4 W/m2 in December (below 313 
nm) [15]. The highest irradiance used in this study (1.18 W/m2) is intermediate between 
summer and winter sunlight UVB irradiance. CLSM showed that 280 nm light inhibited 
EGF-mediated activation of EGFR and inhibited cellular migration (Figs. 6A and 7). It 
has been reported that 280 nm irradiation leads to the arrest of EGFR dependent key 
signaling pathways [14] and leads to conformational changes in the EGF binding site in 
EGFR, impairing the correct interaction with ligands [16]. If 280 nm excitation of GFP 
at the irradiance levels used had affected the structure of GFP, due to photochemistry, it 
would be expected that the fluorescence of the Ser-Tyr-Gly chromophore in GFP would 
have been compromised, as Tyr absorbs at 280 nm. Therefore, we ascertain that 280 nm 
excitation of GPF under the illumination conditions used had no effect on the green 
fluorescence emission intensity distribution of the Ser-Tyr-Gly chromophore in GFP. 
Illumination time was found to be a very important factor: 30 min of 280 nm 
irradiation at 0.09 W/m2 was more efficient than 15 min illumination in preventing 
EGFR activation, filopodia formation and cellular migration (Fig. 6A (panels a5 to a-8) 
and Fig. 7, respectively). This is in agreement with previous results [14] reporting that 
280 nm illumination of cancer cells overexpressing EGFR (A431, human epidermoid 
carcinoma cells and Cal39, derived from human vulva squamous cell carcinoma cells) 
blocked EGFR signaling above a particular illumination time (30 min) at a particular 
irradiance value (0.35 W/m2). In the present study, the efficiency of 280 nm 
illumination in preventing EGFR activation, filopodia formation and cellular migration 
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was tested at an irradiance level (0.27 W/m2) close to what was previously reported 
(0.35 W/m2 [14]) and one order of magnitude lower (0.09 W/m2). Both irradiance levels 
successfully prevented EGF-induced cell migration. As demonstrated in Fig. 9, an 
increase of the irradiation level and exposure time delays or even halts EGFR activation, 
internalization, filopodia formation and cell migration. The blocking effect over EGFR 
signaling by UV light treatment is very marked with 30 min of irradiation with 0.09 and 
0.27 W/m2 light before stimulation with EGF, while treatment with only 15 min of 1.18 
W/m2 light is sufficient to cause an inhibition of EGFR activation.  Bunsen-Roscoe 
reciprocity law i.e., the extent of photochemical effects is determined by cumulative 
irradiance, is particularly evident when comparing results obtained with 15 min 
treatment with the lowest and highest irradiances (0.09 W/m2 and 1.18 W/m2, 
respectively) (Figure S2). With 0.09 W/m2, the achieved blocking effect of EGFR 
signaling starts fading already after 8 min, as signs of activation become visible. The 
highest irradiance tested can block EGF-mediated activation up to 22 min. The 
intermediate irradiance tested does lead to concordant results although not as clearly 
distinguishable, as cellular mechanisms can and certainly do mask this effect. At 16 min 
of exposure to EGF, cells pretreated with 0.27 W/m2 light suggest some cell activation, 
as indicated by the arrows. 
The results presented in this paper are in line with the report that 280 nm light 
induces conformational changes in EGFR, preventing its activation [17]. This is also 
corroborated by Yamauchi et al. [40] and Kawaguchi et al. [42] which showed that 
when pancreatic cells are irradiated at 254 nm there is a downregulation of EGFR 
expression. Both 254nm and 280 nm light lead to disruption of disulphide bridges in 
proteins, such as EGFR, most likely compromising their structure and, therefore, their 
function [43]. 
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The new photonic strategy aims at disrupting the structure and function of EGFR 
and therefore it is targeted to cells overexpressing EGFR, a receptor that is expressed or 
highly expressed in a variety of common solid tumors and associated with poor 
prognosis. EGFR is the target of many chemotherapeutical approaches. High expression 
of EGFR is a hallmark of many types of tumors, such as head and neck, NSCLC, breast, 
prostate, ovarian, glioblastoma, esophageal or skin cancer [44]. In most cases it is 
associated with poor prognosis and several EGFR signaling targeting therapies (e.g. 
erlotinib, cetuximab) have been developed and applied in the clinic. The possibility of 
preventing EGF-mediated activation of EGFR with low dose UV light that could be 
delivered locally using portable LED lights, alone or in synergistic combination with the 
already used chemotherapies, could be helpful almost immediately for battling 
accessible tumors such as skin lesions, ovarian or esophageal cancers among others. In 
the long run, the development of other light delivery systems and the optimization of 
irradiation time/intensity could greatly widen the range of applications. We propose an 
alternative photonic strategy to halt EGFR signaling pathway , at a specific wavelength 
that has the lowest probability in the whole UVB spectrum to induce skin cancer, 
erythema or even keratitis (inflammation of the cornea) [27].  
Since light is used in this putative new therapy, we can confine the illumination 
onto the cancer tissue, minimizing irradiation of healthy cells. The irradiance levels 
used are nevertheless below damaging thresholds for normal cells since the energy per 
unit area applied in our studies is several orders of magnitude below the level known to 
cause DNA photoionization [45] and lead to the formation of cyclobutane pyrimidine 
dimers (CPDs) which is the principal lesion responsible for most DNA damage-
dependent biological effects of sunlight [46,47]. The peak of this action spectrum is 
near 300 nm and decreases rapidly at both longer and shorter wavelengths [48]. The 
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energy per unit area used reporting 280 nm induced CPD formation [49] are up to 100x 
larger than the energy levels per unit area used in this study. Nonetheless, to confirm the 
safety of the light treatment protocols, we have carried out in parallel zebrafish 
embryogenesis studies designed to evaluate possible effects of 8hpf or 24hpf embryo 
irradiation with 5, 15 or 30 minutes of 280nm UV light (at the reported irradiance of 
0.27W/m2) (unpublished data). No cumulative mortality was observed and only 
marginal effects were detected on heart rate and hatching among 8 different 
development parameters assessed. 
The results show that low dose 280 nm light has a potential therapeutic effect in 
cancer treatment. The proposed new photonic therapy may be used alone or combined 
with other cancer therapies. It has advantages over other photonic cancer therapies, such 
as photodynamic therapy (PDT), since there is no need to use a photosensitizer.  
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